Capital & Innovation Workshop

Part I – Understanding the Funding Landscape

Goal: Provide an overview of how clinical trial innovation is funded and the major investment trends shaping the sector.

CHAIRPERSONS:
Lorna Knapstad, Owner, L3 Consulting
Matthieu Ruffin, Vice President, Head Study Leadership, Novartis
Lawrence Tallon, CEO, Medicines and Healthcare Products Regulatory Agency (MHRA)
Niklas Blomberg, PhD, Executive Director, Innovative Health Initiative (IHI)
Maria Koutsopoulou, Senior Vice President, Head of Global Development Operations, Merck KGaA
Christophe Lahorte, PhD, Head, Innovation Office & Scientific Regulatory Advice Unit, famhp (Federal Agency for Medicines and Health)

Part II – How to Raise Capital for Clinical Trial Innovation

Goal: Provide practical insights for biotech and technology companies seeking funding.

PANEL DISCUSSION: Raising Capital for Clinical Trial Innovation: What Investors Really Look For
PANEL MODERATOR:
Eileen Murphy, Conference Producer, Cambridge Healthtech Institute
PANELISTS:
Chelsea Ranger, Chief Business Officer, Possibia; Founder and Chair, Women in Life Science, Norway
Stephen Scaldaferri, Head Vice President, Global Growth, Thermo Fisher Scientific, Inc.

Part III – Why Europe? The Opportunity for Clinical Trial Innovation

Goal: Discuss why Europe is becoming an attractive location for clinical trial innovation and investment.

Who Should Attend

INVESTMENT FIRMS:
Venture Capitalists
Angel Investors
Private Equity Firms
Investment Banks
Senior Investors (Managing Partners/Directors & General Partners)
Investors (Partners, Investors & Principals)
Private Marketing Investing
Portfolio Advisors (Venture & Operating Partners)

CORPORATIONS:
National Government Agencies
Hospitals (Venture & Innovation)
Large Pharma (Clinical, Venture & Innovation)
Small and Mid-Size Biopharma C-Suite Executives
Business Development Heads (SVPs, VPs & Directors)
Innovation & Strategy Managers (SVPs, VPs & Directors)
Corporate Venture Leaders (Managing Directors, Partners & Directors)

START-UPS and GROWTH COMPANIES:
Emerging Company Leaders from Biotech, Digital/AI Health Innovation
Founders & CEOs
C-Suite Executives (CFOs, CSOs, CIOs, CTOs, etc.)
Innovation & Strategy Managers (SVPs, VPs & Directors)

Following the tremendous success of our U.S.-based Clinical Trial Venture, Innovation & Partnering Conference, part of the long-running SCOPE Summit, we are excited to bring this highly regarded program to Europe.

This expansion reflects strong demand from investors, pharma leaders, and innovators for a dedicated forum focused on clinical trial investment, innovation, and strategic partnerships. Building on the proven U.S. model, the European edition will deliver the same high-impact, executive-level experience: connecting key stakeholders, surfacing breakthrough opportunities, and driving the future of clinical research across global markets.

Eileen Murphy, MEd
Conference Producer
(+1) 781-738-0049
emurphy@healthtech.com